What is KPV?
KPV is a very small peptide consisting of three amino acids: **Lysine, Proline, and Valine**. It is the "active core" of the much larger alpha-Melanocyte Stimulating Hormone (alpha-MSH). While alpha-MSH is famous for causing skin tanning, the KPV fragment lacks the tanning properties but retains the intense anti-inflammatory signal.
In research, KPV is being investigated as a safer, non-steroidal alternative for treating chronic inflammatory conditions of the skin, gut, and immune system.
⚗️ Key Research Facts
- Molecular Type: Tripeptide
- Parent Molecule: alpha-MSH
- Primary Goal: Inflammation Suppression
- Bioavailability: High (Oral & SubQ)
Mechanism: NF-κB Inhibition
The core of KPV's research profile is its impact on **NF-κB** (Nuclear Factor kappa B). NF-κB is the master switch that turns on the production of pro-inflammatory cytokines like TNF-alpha and IL-6.
- Intracellular Action: KPV enters the cell and blocks the signaling pathway that activates NF-κB.
- Cytokine Reduction: This leads to a dramatic decrease in the "cytokine storm" associated with chronic inflammatory flares.
- Broad Spectrum: Because NF-κB is a universal driver of inflammation, KPV's potential applications span almost every tissue in the body.
Research in IBD & Gut Health
KPV is unique because it is effectively transported in the intestine by the **PepT1** transporter. This makes it a primary subject for research into **Inflammatory Bowel Disease (IBD)** and Ulcerative Colitis. Research indicates that KPV can significantly reduce the severity of intestinal inflammation and help restore the integrity of the gut lining (the "leaky gut" effect).
Mast Cell Stabilization (MCAS)
Another critical area of study is KPV's role in **Mast Cell Activation Syndrome (MCAS)**. Mast cells are the immune cells that release histamine during an allergic response. Research has shown that KPV can stabilize these cells, preventing them from "degranulating" and releasing the chemicals that cause itching, swelling, and systemic inflammation.
Histamine Management
Helps modulate the immune response in subjects with high histamine sensitivity or chronic hives.
Antimicrobial Effect
Some studies indicate KPV has direct antimicrobial properties against pathogens like *Staph. aureus* and *C. albicans*.
Research Protocols & Dosing
- Administration: Subcutaneous injection or Oral.
- Research Dose: 200 mcg to 500 mcg per day.
- Frequency: Typically administered daily for a 4–8 week protocol.
- Side Effects: Virtually non-existent in literature; some researchers note its extreme safety profile compared to corticosteroids.
- Storage: Lyophilized powder in the freezer. Reconstituted solution in the refrigerator.
Frequently Asked Questions
Will it make me tan?
No. KPV does not bind to the MC1R receptor responsible for melanin production. It is purely an anti-inflammatory agent and does not affect skin pigmentation in research models.
Can it be used with BPC-157?
Yes. Many research models combine KPV with BPC-157 for gut health studies, as they work through complementary pathways: BPC-157 focuses on tissue repair and angiogenesis, while KPV focuses on the suppression of the underlying inflammatory signal.
Where to buy KPV in Canada?
Nūmira Peptides offers high-purity KPV for gastrointestinal and immunological research. Shop KPV →
